Biotest AG
XETRA:BIO

Watchlist Manager
Biotest AG Logo
Biotest AG
XETRA:BIO
Watchlist
Price: 40.2 EUR -4.74% Market Closed
Market Cap: 1.5B EUR

Wall Street
Price Targets

BIO Price Targets Summary
Biotest AG

There are no price targets for BIO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Biotest AG Competitors:
Price Targets
SCLP
Scancell Holdings PLC
219% Upside
CNTB
Connect Biopharma Holdings Ltd
220% Upside
IONS
Ionis Pharmaceuticals Inc
10% Upside
688105
Nanjing Vazyme Biotech Co Ltd
40% Upside
TRDA
Entrada Therapeutics Inc
67% Upside
OXB
Oxford BioMedica PLC
14% Upside
GILD
Gilead Sciences Inc
11% Upside
AMRN
Amarin Corporation PLC
11% Downside

Revenue
Forecast

Revenue Estimate
Biotest AG

For the last 8 years the compound annual growth rate for Biotest AG's revenue is 7%. The projected CAGR for the next 1 year is -1%.

7%
Past Growth
-1%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Biotest AG

For the last 8 years the compound annual growth rate for Biotest AG's operating income is 12%. The projected CAGR for the next 1 year is 25%.

12%
Past Growth
25%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Biotest AG

The compound annual growth rate of Biotest AG's net income for the next 1 year is 121%.

N/A
Past Growth
121%
Estimated Growth
Estimates Accuracy
1%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIO's stock price target?
Not Available

BIO doesn't have any price targets made by Wall Street professionals.

What is Biotest AG's Revenue forecast?
Projected CAGR
-1%

For the last 8 years the compound annual growth rate for Biotest AG's revenue is 7%. The projected CAGR for the next 1 year is -1%.

What is Biotest AG's Operating Income forecast?
Projected CAGR
25%

For the last 8 years the compound annual growth rate for Biotest AG's operating income is 12%. The projected CAGR for the next 1 year is 25%.

What is Biotest AG's Net Income forecast?
Projected CAGR
121%

The compound annual growth rate of Biotest AG's net income for the next 1 year is 121%.

Back to Top